INTERNATIONAL LIVER CANCER ASSOCIATION

International Liver Cancer Association 14th Annual Conference

 

September 11-13, 2020 Virtual Conference
Close
N. Poster
Poster title
Applicant name
Status
  P-001 Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress Robin Kate Kelley Received Received
  P-002 Leap-012: A Randomized, Double-Blind, Phase 3 Study Of Pembrolizumab Plus Lenvatinib In Combination With Transarterial Chemoembolization (Tace) In Patients With Intermediate-Stage Hepatocellular Carcinoma (Hcc) Not Amenable To Curative Treatment Richard Finn Received Received
  P-003 Ramucirumab For Patients With Advanced Hepatocellular Carcinoma And Elevated Alpha Fetoprotein Following A Non-Sorafenib Based Systemic Therapy: Interim Results From An Expansion Cohort Of The Phase 3 Reach-2 Study David Mcilwain Received Received
  P-004 Sorafenib (Sor) Combined With Nivolumab (Nivo) In Advanced Hepatocellular Carcinoma (Hcc): Safety And Efficacy In A Dose Escalation Cohort Bridget Keenan Received Received
  P-005 A Randomized, Placebo-Controlled Study Of Transarterial Chemoembolization Combined With Concurrent Durvalumab Followed By Durvalumab Or Durvalumab Plus Bevacizumab Therapy In Patients With Locoregional Hepatocellular Carcinoma (HCC): EMERALD-1 Humna Rizki Received Received
  P-006 Durvalumab With Or Without Bevacizumab As Adjuvant Therapy For HCC Patients At Risk Of Recurrence After Curative Therapy: EMERALD-2 Humna Rizki Received Received
  P-008 Phase 3 Keynote-937: Adjuvant Pembrolizumab Versus Placebo In Patients With Hepatocellular Carcinoma And Complete Radiologic Response After Surgical Resection Or Local Ablation Arndt Vogel Received Received
  P-009 Hcc Recurrence Post Daa And Its Relation To Treatment Time Of Chronic Hcv Infection Mohamed Fathey Elgazzar Received Received
  P-013 Quantification Of Intratumoral Collagen And Elastin Fibers Within Hepatocellular Carcinoma Tissues Finds Correlations With Clinico-Patho-Radiological Features Junki Maehara Received Received
  P-015 Correlates And Longitudinal Changes In Ultrasound Visualization For Hcc Surveillance In Patients With Cirrhosis Amit Singal Received Received
  P-016 Simple Indicators Of Energy Malnutrition In Patients With Chronic Liver Diseases Hitomi Komiyama Received Received
  P-018 Elecsys PIVKA-II And Elecsys AFP Assays Demonstrate Good Clinical Performance For Hepatocellular Carcinoma (HCC) Diagnosis Across Different Disease Stages And Aetiologies Enrico De Toni Received Received
  P-019 Analytical Performance And Method Comparison Of The Elecsys PIVKA-II Immunoassay As An Aid In Diagnosis Of Hepatocellular Carcinoma (HCC) Enrico De Toni Received Received
  P-021 Immunoscore Classification From Hepatocellular Carcinoma Histopathology Images Using Deep Learning: A Preliminary Study Qiaofeng Chen Received Received
  P-022 Serum Level Of Sulf2 Is Associated With The Severity Of The Liver Disease And Possess A Prognostic Value In Patients With Alcoholic Cirrhosis Erwan Guyot Received Received
  P-023 Liver Visualization For Hepatocellular Carcinoma Surveillance: Performance Boundaries In A Large Multi-Site Practice David Fetzer Received Received
  P-024 Li-Rads Diagnostic Performance Of Hepatocellular Carcinoma In Population With Previous Hepatitis B Virus Infection Zonglin Xie Received Received
  P-025 Usefulness Of Circulating Tumor Cells In The Management Of Patients With Hepatocellular Carcinoma Elena Vargas-Accarino Received Received
  P-027 A Pre-TACE radiomics model to predict HCC progression and recurrence in liver transplantation: a pilot study on a novel biomarker Tommy Ivanics Received Received
  P-028 Purification And Digital Scoring Of Extracellular Vesicles For Detection Of Early-Stage Hepatocellular Carcinoma Vatche Agopian Received Received
  P-029 Clinical Strategy Of Diagnosing Patients With Hepatocellular Carcinoma Based On Latent Transforming Growth Factor-Beta Binding Protein 1 Mohamed Abdel-Samiee Received Received
  P-030 Role Of Contrast-Enhanced Ultrasound As A Secondary Diagnostic Modality In Non-Invasive Diagnostic Algorithms For Hepatocellular Carcinoma Hyo-Jin Kang Received Received
  P-032 The SPRING Protocol Is the Key to Improve MVI Detection Rate Lijuan Liu Received Received
  P-033 Patient Preferences For Hepatocellular Carcinoma Surveillance: A Multicenter Conjoint Analysis Neehar Parikh Received Received
  P-034 Hepatocellular Carcinoma Tumor Volume Doubling Time: A Systemic Review And Meta-Analysis Piyush Nathani Received Received
  P-035 Prediction of post-hepatectomy liver failure in patients with hepatocellular carcinoma based on radiomics using Gd-EOB-DTPA-enhanced MRI: the liver failure (LF) model Yuyan Chen Received Received
  P-037 Usefulness Of Serum Metabolic Profiles For The Differential Diagnosis Of Distal Cholangiocarcinoma And Pancreatic Ductal Adenocarcinoma Rocio IR Macias Received Received
  P-038 MALDI- Imaging Mass Spectrometry Of N-Glycan Profiles Of Molecular Subclasses Of Human Hepatocellular Carcinoma Andrew DelaCourt Received Received
  P-039 Performance Of Imaging Criteria For The Diagnosis Of Hepatocellular Carcinoma In Non-Cirrhotic Patients With Hbv Carlos Moctezuma-Velazquez Received Received
  P-040 A Fucosylated Kininogen-Based Biomarker Panel Is Highly Accurate For Early Detection Hepatocellular Carcinoma In Patients With Cirrhosis: A Phase Iii Biomarker Evaluation Anand Mehta Received Received
  P-041 Clinical Experiences And Resources For Treating Hepatocellular Carcinoma In Africa Vishal Shah Received Received
  P-042 Temporary Trends Of Liver Cancer Incidence Rates In China From 2014 To 2050 Maomao Cao Received Received
  P-045 Ges Score: A Simple Score For Hcc Risk Stratification In Chc Patients With Cirrhosis Who Achieved Svr Following Daa Therapy Gamal shiha Received Received
  P-046 Utilization Of Hepatocellular Carcinoma Surveillance In Patients With Cirrhosis: A Systematic Review And Meta-Analysis Amit Singal Received Received
  P-047 Benefits And Harms Of Hepatocellular Carcinoma Surveillance In A Prospective Cohort Of Patients With Cirrhosis Amit Singal Received Received
  P-048 Prognostic Significance Of Body Composition In Elderly Patients With Hepatocellular Carcinoma Undergoing Trans-Arterial Chemoembolization. Jihye Lim Received Received
  P-049 Macrotrabecular Growth Pattern Is Associated With Poor Prognosis In Patients With Hepatocellular Carcinoma Suhair Al Salihi Received Received
  P-053 Systematic Review And Meta-Analysis Of Validated Prognostic Models For Resected Hepatocellular Carcinoma Patients Berend Beumer Received Received
  P-054 External Validation And Calibration Of The Erasl Risk ScoresResults Of A Dutch And Japanese Cohort Study Berend Beumer Received Received
  P-056 Abnormal And Euthyroid Ranges Of Thyroid Hormones In Serum And Liver Cancer Mortality: A Cohort Study Won Sohn Received Received
  P-059 Blood cell salvage and auto-transfusion does not worsen oncologic outcomes following liver transplantation with incidental HCC: a propensity score matched analysis Tommy Ivanics Received Received
  P-060 Liver transplant, liver resection or ablation as first-line treatment for solitary HCC 3 cm or less: An intention-to-treat analysis Tommy Ivanics Received Received
  P-061 Sex Disparities In Presentation And Prognosis Of Patients With Hepatocellular Carcinoma Nicole Rich Received Received
  P-064 The Influence Of The Extent Of Lymph Node On The Prognosis For Patients With Intrahepatic Cholangiocarcinoma Undergone Surgery Ying Zhang Received Received
  P-065 The Association Between Socioeconomic Status And Hepatocellular Carcinoma Mortality In The United States Neehar Parikh Received Received
  P-066 Overall Survival Is Impacted By Liver Failure And Co-Morbidities Rather Than Etiology Of Cirrhosis In Patients With Hepatocellular Carcinoma Detected During A Surveillance Program Nathalie Ganne-Carrié Received Received
  P-067 Role Of Alpha Fetoprotien Score And Aurora B Kinase In Prediction Of Hepatocellular Carcinoma Recurrence After Microwave Ablation. Hend Naguib Received Received
  P-068 Recurrence Risk Reassessment (R3) Model Based On Explant Features Improves Prediction Of Hcc Recurrence Compared With Existing Models Charlotte Costentin Received Received
  P-069 The Performance Of Non-Invasive Serum Tests In Predicting Clinically Significant Portal Hypertension And Posthepatectomy Liver Failure In Patients With CirrhosisComplicated With Hepatocellular Carcinoma Iuliana Nenu Received Received
  P-072 Silencing Of Hepatic Discoidin Domain Receptor 1 Reduces Murine Liver Metastasis By Colon Carcinoma. Role Of Sinusoidal Discoidin Domain Receptor 1 In Liver Metastasis. Irene Romayor Received Received
  P-074 Animal Models Of Liquid Biopsy In Hepatocellular Carcinoma Reveal Clone-Dependent Release Of Circulating Tumor Dna Ismail Labgaa Received Received
  P-076 Immune-remodeling effects of lenvatinib plus anti-PD1 in a murine model of hepatocellular carcinoma Laura Torrens Received Received
  P-077 Identification Of Neoantigen-Reactive Tumor-Infiltrating T Cell In Hepatocellular Carcinoma. Enric Vercher Herraez Received Received
  P-078 Novel Strategies To Target Mitochondria In Bile Duct Cancers Pietro Carotenuto Received Received
  P-079 Defining The Temporal Evolution Of The Gut Microbiome And Associated Intrahepatic Immune Response In The Mdr2-/- Model Of Hepatocellular Carcinoma Jason Behary Received Received
  P-080 Cyclooxygenase 2 (Cox-2) Inhibition Counteracts Icam-1 Modulation Of Liver Microenvironment During Metastatic Development Alba Herrero Received Received
  P-081 Cold-Inducible Rna Binding Protein As A Vaccination Platform Against Hepatocellular Carcinoma David Repáraz Received Received
  P-082 Identification Of Neoantigens As Potential Vaccines In Hepatocellular Carcinoma. David Repáraz Received Received
  P-083 Silencing Of Ddr1 Expression In Murine C26 Colon Carcinoma Reduces Experimental Liver Metastasis. Blockage Of Ddr1 Phosphorylation In Sinusoidal Cells Diminish Prometastatic Features Of C26 Cells. Irene Romayor Received Received
  P-084 Trem2 Defends The Liver Against Hepatocellular Carcinoma Through Multifactorial Protective Mechanisms Ibone Labiano Received Received
  P-085 Modeling Hepatocellular Carcinoma In The Minipig Barbara Tschida Received Received
  P-086 Activated Peripheral Blood Lymphocytes Of Hepatocellular Carcinoma Patients (Hcc) Are Associated With Increased Risk Of Early Dermatologic Adverse Effects During Sorafenib Treatment Josep Corominas Argente del Castillo Received Received
  P-088 Testis-Associated Lncrnas As Therapeutic Targets Against Hepatocellular Carcinoma Juan Pablo Unfried Received Received
  P-089 Rsk2 Mutation-Driven Mapk Activation Sensitizes Sorafenib Treatment And DrivesCholesterol Metabolism In Hepatocellular Carcinoma Irene Ng Received Received
  P-090 Implications of NOTCH3 Expression and Signaling for Cholangiocarcinogenesis Sarah Fritzsche Received Received
  P-091 Dual Targeting Of Tumor Associated Macrophages And Immunosuppressive Granulocytic Myeloid-Derived Suppressor Cells Augments Pd-1 Blockade In Cholangiocarcinoma Emilien Loeuillard Received Received
  P-092 Characterization Of Chromatin Accessibility In Hepatocellular Carcinoma Cells Using Single Cell Atac Sequencing Amanda Craig Received Received
  P-094 Expression Of P62/Sqstm1 In Hepatocellular Carcinoma And Its Relation To Tumor Recurrence After Radiofrequency Thermal Ablation Assem El-Shendidi Received Received
  P-095 Rac1 Inhibition As A New Therapeutic Target For Hcc Juan Bayo Received Received
  P-098 Hepatic Arterial Infusion Chemotherapy For Post-Transplant Recurrent Hepatocellular Carcinoma After Failure Of Tyrosine Kinase Inhibitors Jinfa Lai Received Received
  P-103 Exposure-response analysis for nivolumab ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040) Onaisa Rizki Received Received
  P-105 Postprogression Survival After Lenvatinib Treatment For Advanced Hepatocellular Carcinoma Yoshiyuki Wada Received Received
  P-107 Effect Of Pembrolizumab (Pembro) On Hepatitis B Virus (Hbv) Load And Aminotransferase (Alt) Levels In Patients (Pts) With Advanced Hepatocellular Carcinoma (Ahcc) In Keynote-224 And Keynote-240 Philippe Merle Received Received
  P-108 Efficacy And Safety Of Lenvatinib As A Salvage Therapy Of Transarterial Treatment For Unresectable Hepatocellular Carcinoma Jaejun Lee Received Received
  P-109 Post-Registration Experience Of Nivolumab Therapy In Patients With Advanced Hepatocellular Carcinoma (Hcc): An International Study. Petros Fessas Received Received
  P-113 Surgical Outcomes Of Hepatocellular Carcinoma Within Milan Criteria In Our Department: Especially Assess By The Timing Of Sustained Virological Response Yuko Takami Received Received
  P-114 Effects Of Molecular Target Agent Therapy In Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study Kazufumi Kobayashi Received Received
  P-115 Sequential Treatment With Sorafenib Followed By Regorafenib In Patients With Unresectable Hepatocellular Carcinoma (HCC): Interim Analysis Of The Observational REFINE Study Kathrina Quinn Received Received
  P-121 Hepatic Immune-Related Adverse Events During Immunotherapy: A Comparison Between Hcc And Liver Metastases From Other Solid Tumors Antonio DAlessio Received Received
  P-122 Tumor Burden Score: A Useful Tool To Predict Immune-Related Hepatotoxicity During Immunotherapy For Hepatocellular Carcinoma Antonio DAlessio Received Received
  P-123 Immunotherapy And Immune-Related Hepatitis In Hepatocellular Carcinoma: Outcomes And Tissue Biomarker Analysis Nicola Personeni Received Received
  P-126 Nuclear Protein 1 (Nupr1) Expression Contributes To Sorafenib Resistance In Hepatocellular Carcinoma Cells Through Protective Autophagy Activation And P73 Inhibition Melchiorre Cervello Received Received
  P-127 Real-Life Experience Of Regorafenib In Patients With Advanced Hepatocellular Carcinoma In China Jingyu Hou Received Received
  P-128 Third-Line Chemotherapy In Advanced Biliary Cancers (Abc): Pattern Of Care, Treatment Outcome And Prognostic Factors From A Multicenter Study. Massimiliano Salati Received Received
  P-129 Pilot Study Of Transarterial Radioembolization With Yttrium-90 In Patients With Hepatocellular Carcinoma Pablo Florez-Diez Received Received
  P-131 The Efficacy And Safety Of Concurrent Chemoradiotherapy In Patients With Unresectable Hepatocellular Carcinoma Hyun Woong Lee Received Received
  P-133 Tenofovir Vs Entecavir On Post-Operative Recurrence-Free And Overall Survival Of Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Jonggi Choi Received Received
  P-135 Survival And Morbidity Following Stereotactic Radiotherapy Of Hepatocellular Carcinoma: A 10 Year Single Institution Experience. Hanna Rahbek Mortensen Received Received
  P-136 Transarterial Chemoembolization Versus Transarterial Radioembolization For Patients With Hepatocellular Carcinoma: A Meta-Analysis Neehar Parikh Received Received
  P-137 Total Tumor Volume As A Prognostic Value For Survival Following Liver Resection In Patients With Hepatocellular Carcinoma. Retrospective Cohort Study Mohamed Abdel-Samiee Received Received
  P-138 Treatment Sequencing Options In Advanced Hepatocellular Carcinoma: Preliminary Data From A Single-Centre Retrospective Cohort Irene Pecora Received Received
  P-139 Selective Internal Radiation Therapy In Patients With Hepatocellular Carcinoma: A Retrospective Danish Study Of Efficacy Gerda Elisabeth Villadsen Received Received
  P-140 Immune Profiling Of Combined hepatocellular-Cholangiocarcinoma Julien Calderaro Received Received
  P-200 Prueba Daniel Zaldumbide Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Cristina Miralles
Hours: Mon-Fri 8:30-15:00
04:30
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

INTERNATIONAL LIVER CANCER ASSOCIATION

International Liver Cancer Association 14th Annual Conference

 

September 11-13, 2020 Virtual Conference
HELP LINE
Manage Orders
FAQs



Poster submission deadline 24 August at 23:59 GMT+1

Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 11/07/2020 TO 11/09/2021
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                  
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 04/09/2020
Upload Poster
Upload Oral Presentation of Video
Upload
Poster
Upload Oral
Presentation or Video




PosterSessionOnline
Logo Draft
 
Logo Cert